🇺🇸 MRK — Merck & Co., Inc.
Salud CompraPrecio actual
146,73 USD
Máx. histórico
156,45
73 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-6,21%
Rango 52 semanas
85,24 – 156,92
Variación hoy
-0,14%
Cierre anterior
146,94
Rango de hoy
142,80 – 147,48
Volumen hoy
7.462.267
Peor caída histórica
-68,62%
28/12/2000 → 09/03/2009
Recuperado en 1796 días
Volatilidad anualizada ⓘ
25,43%
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Salud
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 148,21 (puede no estar actualizado)
- Dividend yield
- 2,31% (puede no estar actualizado)
- Precio objetivo analistas
- 161,53 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 20 horas
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 15/09/2026 | 0,8500 USD |
| 15/06/2026 | 0,8500 USD |
| 16/03/2026 | 0,8500 USD |
| 15/12/2025 | 0,8500 USD |
| 15/09/2025 | 0,8100 USD |
| 16/06/2025 | 0,8100 USD |
| 17/03/2025 | 0,8100 USD |
| 16/12/2024 | 0,8100 USD |
| 16/09/2024 | 0,7700 USD |
| 17/06/2024 | 0,7700 USD |
| 14/03/2024 | 0,7700 USD |
| 14/12/2023 | 0,7700 USD |
| 14/09/2023 | 0,7300 USD |
| 14/06/2023 | 0,7300 USD |
| 14/03/2023 | 0,7300 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 20/11/2007 | 55,56 | 55,73 | 54,71 | 55,27 | -0,57% | 1,82% | 14.977.597 |
| 19/11/2007 | 55,25 | 55,92 | 55,14 | 55,58 | -0,22% | 1,40% | 14.248.608 |
| 16/11/2007 | 55,75 | 55,75 | 54,50 | 55,71 | +0,79% | 2,24% | 13.664.034 |
| 15/11/2007 | 54,35 | 56,19 | 54,24 | 55,27 | +1,08% | 3,60% | 16.544.357 |
| 14/11/2007 | 53,91 | 55,04 | 53,91 | 54,68 | -0,33% | 2,09% | 10.995.721 |
| 13/11/2007 | 53,84 | 54,90 | 53,43 | 54,86 | +2,68% | 2,73% | 16.533.248 |
| 12/11/2007 | 53,35 | 54,07 | 52,80 | 53,43 | +0,16% | 2,40% | 11.320.810 |
| 09/11/2007 | 52,98 | 55,10 | 52,98 | 53,34 | +2,06% | 4,00% | 26.584.616 |
| 08/11/2007 | 51,97 | 52,62 | 51,58 | 52,26 | +1,05% | 2,00% | 18.793.574 |
| 07/11/2007 | 52,66 | 53,37 | 51,65 | 51,72 | -3,20% | 3,26% | 14.087.111 |
| 06/11/2007 | 53,42 | 53,69 | 53,13 | 53,43 | +0,11% | 1,05% | 9.805.822 |
| 05/11/2007 | 52,48 | 54,25 | 52,48 | 53,37 | -0,20% | 3,36% | 12.336.637 |
| 02/11/2007 | 55,38 | 55,38 | 53,02 | 53,47 | -2,30% | 4,26% | 17.646.958 |
| 01/11/2007 | 55,23 | 55,69 | 54,57 | 54,73 | -1,54% | 2,02% | 12.644.749 |
| 31/10/2007 | 55,07 | 55,59 | 54,63 | 55,59 | +0,69% | 1,75% | 11.615.298 |
| 30/10/2007 | 55,15 | 55,49 | 54,95 | 55,21 | +0,16% | 0,97% | 10.659.837 |
| 29/10/2007 | 55,02 | 55,51 | 54,69 | 55,12 | +0,33% | 1,49% | 13.872.481 |
| 26/10/2007 | 54,46 | 55,20 | 54,39 | 54,94 | +0,91% | 1,49% | 11.795.974 |
| 25/10/2007 | 53,63 | 54,63 | 53,41 | 54,45 | +1,53% | 2,28% | 13.313.058 |
| 24/10/2007 | 53,78 | 54,15 | 53,19 | 53,63 | -0,28% | 1,79% | 18.176.093 |
| 23/10/2007 | 52,34 | 53,85 | 51,53 | 53,78 | +3,15% | 4,43% | 19.709.841 |
| 22/10/2007 | 51,21 | 52,43 | 50,37 | 52,14 | +2,88% | 4,02% | 20.319.672 |
| 19/10/2007 | 50,68 | 51,76 | 50,52 | 50,68 | -0,52% | 2,43% | 15.173.573 |
| 18/10/2007 | 50,57 | 51,19 | 50,56 | 50,94 | -0,06% | 1,25% | 7.104.602 |
| 17/10/2007 | 50,81 | 51,05 | 50,35 | 50,97 | +0,74% | 1,37% | 11.323.745 |
| 16/10/2007 | 50,74 | 50,87 | 50,27 | 50,60 | -0,49% | 1,18% | 8.524.118 |
| 15/10/2007 | 51,53 | 51,53 | 50,66 | 50,85 | -0,41% | 1,69% | 7.411.351 |
| 12/10/2007 | 50,75 | 51,22 | 50,38 | 51,06 | +0,89% | 1,65% | 8.186.452 |
| 11/10/2007 | 50,65 | 51,23 | 50,36 | 50,61 | -0,36% | 1,71% | 7.812.630 |
| 10/10/2007 | 51,17 | 51,38 | 50,72 | 50,79 | -0,75% | 1,31% | 6.023.275 |